Home » Newsletters » BioWorld Science

BioWorld Science

Sep. 30, 2005

View Archived Issues

Usnic acid exerts nongenotoxic anticancer effects in vitro

COL-3 blocks PKC activity and histamine release in mast cells

Lexicon Genetics updates small molecule drug discovery program

Agonists of mGlu8 and mGlu2/3 receptors may be useful for mood and anxiety disorders

Gene Logic to seek new therapeutic indications for Pfizer drugs

Antiviral effects reported for celgosivir in patients with chronic hepatitis C

Kissei launches Salagen for radiation-induced dry mouth in Japan

Santen to develop rivoglitazone for corneal and conjunctival epithelial disorders

Proof-of-concept study for DDP-733 in constipation-predominant IBS

Ispinesib and SB-743921 make progress under Cytokinetics and GSK alliance

ArQule changes focus, updates pipeline

AVI BioPharma begins HCV study for AVI-4065

FDA request further phase II study for Reverset prior to phase III

Phase I study investigates systemic delivery of Reolysin in solid tumors

Osteologix completes phase I study of NBS-101 for osteoporosis

Glycominds test may predict active MS

Validation of computerized prediction of polymorphs

Novel multifunctional agent for neuroprotection

A new class of antioxidants attenuates neurotoxicity in MPTP model of Parkinsonism

Dual CysLT1/ CysLT2 receptor antagonist for asthma

CE-590 useful for osteoporosis in men with low gonadal function

Oral LY-293111 safe in phase I dose-finding study in cancer patients

Trabectedin metabolism, excretion studied in humans

Angeliq receives FDA approval

DiObex receives fast track designation for Very Low Dose Glucagon

Critical Therapeutics' sNDA approved to manufacture and market Zyflo

Novel diagnostic assay for bipolar disorder claimed by Garvan Institute of Medical Research

TAK-536 prodrugs claimed by Takeda for cardiovascular disorders

AAV-GAD gene therapy reported effective in advanced PD

Patents reveal novel agents for asthma, COPD, etc.

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...